The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
1,100 jobs Number of planned job creations
Announcement Date
24 January 2006
Employment effect (start)
1 June 2006
Foreseen end date
Description
US drug giant Amgen wants to recruit up 750 graduates for a new 820 million plant in Cork, which will open in 2009 and employ 1,100 people by 2010. The group will receive grant assistance from IDA Ireland to develop a new manufacturing complex on a 133-acre greenfield site in Cork. Construction will begin later in 2006 after Amgen, the world's biggest biopharmaceutical group, chose not to bring its investment to Switzerland or Singapore, which had sought the project.
Sources
20 January 2006: The Irish Times
Citation
Eurofound (2006), Amgen, Business expansion in Ireland, factsheet number 63073, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/63073.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
